利索-全球专利检索

  1. 登录
  2. 注册
发明授权
CN101856364B R′-β-D-吡喃果糖苷(R′-β-D-fructopyranoside)在制备防治癌细胞扩散转移药物的用途及应用 失效 - 权利终止

  • 专利标题： R′-β-D-吡喃果糖苷(R′-β-D-fructopyranoside)在制备防治癌细胞扩散转移药物的用途及应用
  • 专利标题（英）： Purpose and application of R'-beta-D-fructopyranoside in preparing medicament for preventing and treating cancer cell diffusion transfer
  • 申请号： CN201010208059.1
    申请日： 2010-06-11
  • 公开(公告)号： CN101856364B
    公开(公告)日： 2012-05-09
  • 发明人: 杨浚
  • 申请人： 杨浚
  • 申请人地址： 湖南省岳阳市南湖大道653号市科技局大院
  • 专利权人： 杨浚
  • 当前专利权人： 杨浚
  • 当前专利权人地址： 湖南省岳阳市南湖大道653号市科技局大院
  • 主分类号： A61K31/7028
  • IPC分类号： A61K31/7028 ;  A61K31/351 ;  A61K31/704 ;  A61P35/00 ;  A61P35/04
R′-β-D-吡喃果糖苷(R′-β-D-fructopyranoside)在制备防治癌细胞扩散转移药物的用途及应用
摘要：
本发明公开了“R′-β-D-吡喃果糖苷(R′-β-D-fructopyranoside)”在制备防治癌细胞扩散转移药物的用途及应用。首次利用R′-β-D-吡喃果糖苷对癌细胞扩散转移的阻抑作用，制备防治癌细胞扩散转移的药物，并临床应用于胃癌、肝癌、肠癌等消化系统的癌症扩散转移的防治；配合放化疗防治胃癌细胞扩散转移时，病人血常规正常保持率为70％，血T淋巴细胞亚群正常保持率为70％，肝肾功能正常保持率为80％以上的显著高效低毒效果，解决了至今没有低毒高效的胃癌扩散转移防治药物的难题。
摘要（英）：

The invention discloses a purpose and application of R'-beta-D-fructopyranoside in preparing a medicament for preventing and treating cancer cell diffusion transfer. The medicament for preventing and treating cancer cell diffusion transfer is prepared by firstly utilizing the depression action of R'-beta-D-fructopyranoside on cancer cell diffusion transfer and is clinically applied to preventing and treating cancer cell diffusion transfer of digestive systems such as gastric cancer, liver cancer, intestinal cancer and the like; when matching with concurrent chemoradiotherapy for preventing and treating cancer cell diffusion transfer, the invention achieves the remarkable high-efficiency and low-toxicity effects that the normal retention rate of the hematic convention of a patient is 70 percent, the normal retention rate of blood T lymphocell subgroup is 70 percent, and the normal retention rate of hepatic/renal function is over 80 percent, and solves the problem that no medicaments for preventing and treating cancer cell diffusion transfer appear till now.

公开/授权文献
0/0